Pharmacology Watch – July 1, 2015
July 1, 2015
View Issues
-
Beta-blockade Use in Non-cardiac Surgery Patients
Perioperative beta-blockade appears to be beneficial for patients with high cardiac risk factors undergoing NCS, but it increased the risk of death in those with no cardiac risk factors.
-
Addition of Ezetimibe to Simvastatin May Improve CV Outcomes
A new study suggests the addition of ezetimibe to simvastatin may improve cardiovascular outcomes in patients with acute coronary syndrome, although the effect is modest.
-
FDA Actions
The FDA has approved two drugs for the treatment of diarrhea-predominant irritable bowel syndrome.